PRODURA
DEAD

Serial Number

86543055

Owner

ALLERGAN SALES, LLC

Attorney

Matthew O. Brady

Filing Date

Feb 23, 2015

Add to watchlist:

No watchlists yet
View on USPTO

PRODURA Trademark

Serial Number: 86543055

PRODURA is a trademark filed by ALLERGAN SALES, LLC on February 23, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ALLERGAN SALES, LLC (493 trademarks)

5 GIRALDA FARMS
MADISON, NJ 07940

Entity Type: 16

ACTAVIS, INC. (216 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

February 23, 2015

Registration Date

Not Registered

Goods & Services

Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 3, 2018 ASGN
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 19, 2016 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 19, 2016 ABN2
ASSIGNED TO EXAMINER
Jan 19, 2016 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2015 CNRT
ASSIGNED TO EXAMINER
May 29, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2015 NWOS
NEW APPLICATION ENTERED
Feb 26, 2015 NWAP